Page URL: https://www.bionews.org.uk/page_158163

Bio-Rad and 10x Genomics settle multiple patent rows

2 August 2021
Appeared in BioNews 1106

Two rival biotechnology companies have settled a long-running patent dispute. 

Bio-Rad Laboratories Inc and 10x Genomics Inc, both based in California, have settled their disputes over patents related to single-cell analysis and microfluidics. The global settlement resolves multiple lawsuits between the two companies and dismisses all infringement claims.

As part of the deal, the parties signed a cross-licence agreement, granting each other a non-exclusive, worldwide, royalty-bearing licence to develop products and services related to single-cell analysis. They will continue to pay each other royalties from licensed products and services until 2030. 

Single-cell analysis is an experimental approach to understand variations among cell in a cell population, whether that is in an organ, a tissue or in a cell culture in a Petri dish in a laboratory. It can be used to look at the genome (DNA), transcriptome (RNA) or proteome (proteins) to understand exactly which genes are active in a cell at a given time.

Most approaches to single-cell analysis use microfluidic systems (sometimes described as 'labs-on-a-chip') which use tiny channels on a silicone, glass or polymer substrate and allow for high-throughput and accurate sequencing. These technologies have a wide range of applications across biological research and clinical health settings.

The two companies had been in dispute over the patents since 2014, and had ongoing court cases in Massachusetts, Delaware, California, Germany, and before the International Trade Commission. 
 

SOURCES & REFERENCES
10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad
10x Genomics |  27 July 2021
Bio-Rad, 10x Genomics settle genomics patent war
Reuters |  27 July 2021
Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations
Business Wire |  27 July 2021
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
1 June 2021 - by Michaela Chen 
A long-running court case over non-invasive prenatal testing patents has been settled...
24 May 2021 - by David Cansfield 
An automated embryo freezing process has been developed to reduce the likelihood of damage from freezing, or 'cryoinjuries', that can occur when the process is performed manually...
1 July 2019 - by Dr Yvonne Collins 
The US patent office has declared an 'interference' - re-opening the long-running dispute between the University of California (UC), Berkeley and the Broad Institute in Cambridge, Massachusetts, over who invented CRISPR genome editing first...
17 September 2018 - by Jen Willows 
A US appealĀ court judgment in favour of the Broad Institute may mark the close of the long-running dispute over the US patent for the use of CRISPR/Cas9 in animal and plant cells...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.